There are some tricks of the dermatologists’ trade when it comes to optimizing cosmeceutical use by complementing procedures with products, according to New Orleans, La., dermatologist Mary P. Lupo, M.D.
Microneedling techniques are mimicking results often associated with laser treatment, according to Tina S. Alster, M.D., director of Washington Institute of Dermatologic Laser Surgery, Washington, DC, who presented “Will Microneedling Replace Lasers?” at the 2016 American Society for Dermatologic Surgery (ASDS) annual meeting in New Orleans.
Researchers presented new data on the use of the fully human IL-17A inhibitor Cosentyx (secukinumab, Novartis) in moderate-to-severe psoriasis, at the 25th European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria, September 28 through October 2, 2016.
Nearly 100% of patients with clinically localized prostate cancer, detected by PSA testing, survive at an average 10 years’ follow-up, regardless of whether they had active monitoring, radical prostatectomy, or radiotherapy, according to new study results.
A report published by U.S. based market research company Grand View Research suggests the global skincare products market will reach $196.67 billion by 2024, up from an estimated $129.21 billion in 2015.
There are important differences in and misconceptions about the prevalence, clinical presentation and treatment of skin of color versus Caucasian psoriasis patients. Dermatologist Andrew F. Alexis, M.D., M.P.H., share his insight about what dermatologists need to know when treating psoriasis skin of color patients.
Although pediatric atopic dermatitis and acne have some similarities among children with skin of color and lighter-skinned children, there are important differences when these common skin conditions affect darker skin types.